Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00WZO
|
||||
Former ID |
DNC012366
|
||||
Drug Name |
A-70108
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530404] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H17NO3
|
||||
Canonical SMILES |
C1C(OC(C2=C1C(=C(C=C2)O)O)CN)C3=CC=CC=C3
|
||||
InChI |
1S/C16H17NO3/c17-9-15-11-6-7-13(18)16(19)12(11)8-14(20-15)10-4-2-1-3-5-10/h1-7,14-15,18-19H,8-9,17H2/t14-,15-/m0/s1
|
||||
InChIKey |
SUHGRZPINGKYNV-GJZGRUSLSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | D(2) dopamine receptor | Target Info | Inhibitor | [530404] | |
Dopamine D1 receptor | Target Info | Inhibitor | [530404] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Dopamine receptor mediated signaling pathway | |||||
Nicotine pharmacodynamics pathwayP05912:Dopamine receptor mediated signaling pathway | |||||
PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.